Rhenman & Partners Asset Management’s Alignment Healthcare ALHC Stock Holding History
Bought
Maintained
Sold
Other funds holding ALHC
VPM
VCM
HRCM
Rhenman & Partners Asset Management's ALHC Position: Q1 2026 in Review
Rhenman & Partners Asset Management increased its Alignment Healthcare (ALHC) stake by 4.4% in Q1 2026, buying an estimated $884K and bringing the position to 1,053,450 shares worth $18.6M. The position accounts for 2.29% of the portfolio, ranked #10.
Rhenman & Partners Asset Management first reported a position in ALHC in Q3 2022 and has held it in 15 quarters since. The position peaked at $25.8M in Q3 2025. 293 funds tracked by Wall St. Rank hold ALHC as of Q1 2026.
- Rhenman & Partners Asset Management held 1,053,450 shares of Alignment Healthcare worth $18.6M as of Q1 2026.
- Rhenman & Partners Asset Management bought 44,000 Alignment Healthcare shares in Q1 2026, an estimated $884K.
- Alignment Healthcare made up 2.29% of Rhenman & Partners Asset Management's portfolio in Q1 2026, its #10 holding.
- Rhenman & Partners Asset Management first reported a position in Alignment Healthcare in Q3 2022 and has held it in 15 quarters since.
- Rhenman & Partners Asset Management's Alignment Healthcare position peaked at $25.8M in Q3 2025.
- 293 funds tracked by Wall St. Rank held Alignment Healthcare as of Q1 2026.
Based on Rhenman & Partners Asset Management's 13F filing for Q1 2026, filed 14 May 2026.